Evidence map›Paper›PMID 31857778›Full record

ArticleWorld journal of gastroenterology2019

Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma.

Kazuhiro Toriyama, Masahiro Tajika, Tsutomu Tanaka, Makoto Ishihara, Yutaka Hirayama, Sachiyo Onishi, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Shinpei Matsumoto and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Updated evidence on the accuracy ofQuantitative imaging in medicine and surgery · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Scientific reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Kazuhiro ToriyamaDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Masahiro TajikaDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. mtajika@aichi-cc.jp.
Tsutomu TanakaDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Makoto IshiharaDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Yutaka HirayamaDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Sachiyo OnishiDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Nobumasa MizunoDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Takamichi KuwaharaDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Nozomi OkunoDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Shinpei MatsumotoDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Eiichi SasakiDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Tetsuya AbeDepartment of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Yasushi YatabeDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Kazuo HaraDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.
Tsuneo TamakiEast Nagoya Imaging Diagnosis Center, Nagoya 464-0044, Japan.
Yasumasa NiwaDepartment of Endoscopy, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.
Aichi Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent advances in endoscopic technology, especially magnifying endoscopy with narrow band imaging (ME-NBI) enable us to detect superficial esophageal squamous cell carcinoma (ESCC), but determining the appropriate method of resection, endoscopic resection (ER)

aimTo investigate the association between FDG uptake and the clinicopathological characteristics of superficial ESCC and its usefulness of combination of FDG-PET and ME-NBI for determining the treatment strategy for superficial ESCC.

methodsA database of all patients with superficial ESCC who had undergone both ME-NBI and FDG-PET for pre-treatment staging at Aichi Cancer Center Hospital between January 2008 and November 2018 was retrospectively analyzed. FDG uptake was defined positive or negative whether the primary lesion was visualized or could be distinguished from the background, or not. The invasion depth of ESCC was classified according to the Japan Esophageal Society. Primary endpoint is to evaluate the association between FDG uptake and clinicopathological characteristics of superficial ESCC. Secondary endpoint is to investigate the efficacy of combination of FDG-PET and ME-NBI for determining the treatment strategy for superficial ESCC.

resultsA total of 82 lesions in 82 patients were included. FDG-PET showed positive uptake in 29 (35.4%) lesions. Univariate analysis showed that uptake of FDG-PET had significant correlations with circumferential extension (

conclusionFDG uptake was correlated with the invasion depth of superficial ESCC. Combined use of FDG-PET and ME-NBI, especially with the microvascular findings of Type B2 and B3, is useful to determine whether ER is indicated for the lesion.

Indexed as

Fluorodeoxyglucose F18Narrow Band ImagingPositron Emission Tomography Computed TomographyAgedCarcinoma, Squamous CellEsophageal NeoplasmsEsophagoscopyEsophagusFemaleHumansJapanMaleMiddle AgedPredictive Value of TestsRetrospective StudiesFluorodeoxyglucose F1818F-fluorodeoxyglucose positron emission tomographyMagnifying endoscopyNarrow band imagingSquamous cell carcinomaSuperficial esophageal cancerTreatment strategy

Identifiers

PMID31857778
PMCPMC6920656
OpenAlexW2998558323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.